Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Arrhythmias, Cardiac

capecitabine has been researched along with Arrhythmias, Cardiac in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Banzato, A; Bergamo, F; Berretta, M; Bidoli, E; Buonadonna, A; De Angelis, G; De Paoli, A; Guglielmi, A; Herrmann, J; Innocente, R; Lestuzzi, C; Lonardi, S; Sinagra, G; Stolfo, D; Tartuferi, L; Viel, E1
Larsen, FO; Nielsen, DL; Polk, A; Schou, M; Shahmarvand, N; Vaage-Nilsen, M; Vistisen, K1
Kok, WE; Koopman, M; Kwakman, JJ; Mol, L; Punt, CJ; Simkens, LH1

Other Studies

3 other study(ies) available for capecitabine and Arrhythmias, Cardiac

ArticleYear
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
    The oncologist, 2022, 03-04, Volume: 27, Issue:2

    Topics: Arrhythmias, Cardiac; Capecitabine; Cardiotoxicity; Exercise; Humans; Incidence; Prospective Studies

2022
Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
    BMJ open, 2016, 10-19, Volume: 6, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Breast Neoplasms; Capecitabine; Cardiotoxicity; Chest Pain; Comorbidity; Denmark; Female; Humans; Incidence; Middle Aged; Myocardial Infarction; Neoplasm Metastasis; Retrospective Studies; Risk Factors

2016
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 76

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bevacizumab; Capecitabine; Carcinoma; Cardiotoxicity; Chest Pain; Colorectal Neoplasms; Heart Failure; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Neoplasm Metastasis; Netherlands; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Retrospective Studies

2017